SCHEMBL4886159

SCHEMBL4886159

CN(c1ccc(F)cc1)c1ncccn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.44
CES1 P23141 1/20 0.41
APP P05067 1/20 0.41
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
GRM1 Q13255 2/20 0.38
HDAC1 Q13547 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
CYP1A2 P05177 3/20 0.36
CYP3A4 P08684 3/20 0.36
CYP2D6 P10635 3/20 0.36
CYP2C9 P11712 3/20 0.36
MAPK1 P28482 3/20 0.36
CYP2C19 P33261 3/20 0.36
LMNA P02545 2/20 0.36
MEN1 O00255 2/20 0.36
USP2 O75604 2/20 0.36
ALDH1A1 P00352 2/20 0.36
TP53 P04637 2/20 0.36
ALOX15 P16050 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29912449 0.80 CYP2D6 (0.44) KMT2ACES1APPGRM1CYP2D6
SCHEMBL13338158 0.80 CYP2D6 (0.44) KMT2ACES1APPGRM1CYP2D6
SCHEMBL2567211 0.80 PTGS1 (0.39) CES1APPPTGS1PTGS2HDAC1
SCHEMBL3385311 0.79 HDAC1 (0.47) KMT2AHDAC1HDAC6CYP1A2CYP3A4
SCHEMBL8119143 0.78 ALDH1A1 (0.50) KMT2ACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL1120950 0.78 CES2 (0.41) KMT2ACES1APPHDAC1HDAC6
SCHEMBL13338132 0.78 APP (0.52) KMT2ACES1APPCYP1A2MAPK1
SCHEMBL2567160 0.76 ALDH1A1 (0.43) KMT2ACES1APPPTGS1PTGS2
SCHEMBL2566482 0.76 ALDH1A1 (0.38) KMT2AAPPPTGS1PTGS2HDAC1
SCHEMBL5998627 0.76 CHRM5 (0.52) KMT2ACES1APPGRM1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080153843-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS GRUENENTHAL GMBH (DE) 2008-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080153843-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS SULT2A1, STS, SULT1A1 KMT2A 1686/4885CES1 465/4885APP 2682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.